Some experts champion soy for its potential protective effects, while others raise concerns about its influence on hormone-related cancers, especially breast cancer. This post explores both perspectives, reviews the latest research, and offers practical nutrition tips for cancer patients considering soy in their diets.
Nutrition Tips for Cancer Patients: The Soybean Debate Read More »
Prostate cancer remains one of the most common cancers affecting men worldwide, with the American Cancer Society estimating about 299,010 new cases and 35,250 deaths in the United States alone in 2024.
Unseen Until It’s Too Late: Understanding the Diagnostic Challenges of Prostate Cancer Read More »
Circulating tumor DNA (ctDNA) and minimal residual disease (MRD) testing are rapidly transforming the landscape of cancer care. By offering a noninvasive window into the molecular status of a patient’s disease, these technologies are enabling earlier detection of recurrence, more precise monitoring of treatment response, and increasingly personalized therapeutic strategies.
The Role of ctDNA/MRD Testing in Cancer: Promise, Practice, and Pitfalls Read More »
The past two months have brought exciting progress in cancer care, with new therapies offering hope for better outcomes and fewer side effects. Below, we break down the latest updates in simple terms, focusing on how these advances might help patients and families navigate treatment decisions.
Cancer Treatment Breakthrough Updates – April / May 2025 Read More »
This blog explores these novel treatments, their efficacy in specific NSCLC populations, and their potential pathway to US approval.
Emerging NSCLC Treatments: Novel Therapies from Global Markets Awaiting US Approval Read More »
PD-1/PD-L1 inhibitors have transformed cancer care, but their immune-activating mechanisms often lead to diverse side effects requiring tailored management. By categorizing these adverse events and pairing them with evidence-based strategies, patients and clinicians can better navigate treatment challenges. Below, we explore common and rare side effects, their clinical presentations, and practical management approaches, enriched with real-world patient experiences.
Managing PD-1/PD-L1 Immunotherapy Side Effects: Strategies and Patient Insights Read More »
This post explores how docetaxel works, its effectiveness in treating various cancers, its common side effects, and practical ways to manage them.
Understanding Docetaxel: Effectiveness and Managing Side Effects in Cancer Treatment Read More »
Key advancements across cancer types from AACR 2025 highlight progress in targeted therapies, immunotherapies, and innovative technologies, with several treatments entering late-stage development or regulatory review
Treatment Progress: Key Findings from AACR 2025 Read More »
Triple-negative breast cancer (TNBC) is one of the toughest forms of breast cancer to treat — but research is moving fast. In this article, we’ll explain the major challenges, clear up common myths, and guide you through current treatment options by stage. We’ll also highlight promising new therapies and share a list of ongoing clinical trials that could shape the future of TNBC care. Whether you’re a patient, caregiver, or supporter, this guide is made to be clear, hopeful, and easy to follow.
Triple-Negative Breast Cancer: Challenges, Current Care, and New Hope Read More »
A 49-year-old man with metastatic rectal cancer to the liver saw disease progression despite multiple treatments. After starting anti-PD-1 immunotherapy, his tumors shrank dramatically—showing promising results after other therapies failed.
Turning Point in the Fight Against Liver Metastases Read More »
